Advertisement

Deflux Calcification Leading to Delayed Obstruction and Loss of Renal Function: A Case Report

      ABSTRACT

      Dextranomer/hyaluronic acid (Deflux) has been widely used in the treatment of vesicoureteral reflux in the pediatric population. It has demonstrated acceptable early efficacy with minimal morbidity. Early complications from Deflux have been reported to occur in approximately 1% of cases. However, late complications from Deflux use, including calcification and delayed ureteral obstruction, are less well understood. We present the case of an asymptomatic 11 year old girl with severe ipsilateral hydroureteronephrosis, identified nearly 8 years after treatment. This case details a rare instance of loss of renal function after Deflux use in a patient with no apparent risk factors.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Vandersteen D.R.
        • Routh J.C.
        • Kirsch A.J.
        • et al.
        Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic acid copolymer.
        J Urol. 2006; 176 (PMID: 16952696): 1593-1595https://doi.org/10.1016/j.juro.2006.06.101
        • Yankovic F.
        • Swartz R.
        • Cuckow P.
        • et al.
        Incidence of Deflux® calcification masquerading as distal ureteric calculi on ultrasound.
        J Pediatr Urol. 2013; 9 (Epub 2012 Nov 24PMID: 23186595): 820-824https://doi.org/10.1016/j.jpurol.2012.10.025
        • Sargent M.A.
        What is the normal prevalence of vesicoureteral reflux?.
        Pediatr Radiol. 2000; 30 (PMID: 11009294): 587-593https://doi.org/10.1007/s002470000263
        • Kalisvaart J.F.
        • Scherz H.C.
        • Cuda S.
        • Kaye J.D.
        • Kirsch A.J.
        Intermediate to long-term follow-up indicates low risk of recurrence after double HIT endoscopic treatment for primary vesico-ureteral reflux.
        J Pediatr Urol. 2012; 8 (Epub 2011 Aug 4. PMID: 21820358): 359-365https://doi.org/10.1016/j.jpurol.2011.07.006
        • Zyczkowski M.
        • Prokopowicz G.
        • Zajęcki W.
        • Paradysz A.
        Complications following endoscopic treatment of vesicoureteric reflux with Deflux(®) - two case studies.
        Cent Eur J Urol. 2012; 65 (Epub 2012 Dec 11. PMID: 24578970. PMCID: PMC3921807): 230-231https://doi.org/10.5173/ceju.2012.04.art12
        • Rubenwolf P.C.
        • Ebert A.K.
        • Ruemmele P.
        • Rösch W.H.
        Delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (Deflux) injection for treatment of vesicoureteral reflux in children: a case series.
        Urology. 2013; 81 (PMID: 23452811): 659-662https://doi.org/10.1016/j.urology.2012.11.044
        • Romain J.
        • Fourcade L.
        • Centi J.
        • et al.
        Delayed-onset ureteral obstruction and calcification masquerading as renal colic following deflux injection.
        Urology. 2016; 94 (Epub 2016 Mar 9. PMID: 26970448): 218-220https://doi.org/10.1016/j.urology.2016.03.001
        • Friedmacher F.
        • Puri P.
        Ureteral obstruction after endoscopic treatment of vesicoureteral reflux: does the type of injected bulking agent matter?.
        Curr Urol Rep. 2019; 20 (PMID: 31289951): 49https://doi.org/10.1007/s11934-019-0913-5
        • García-Aparicio L.
        • Rodo J.
        • Palazon P.
        • et al.
        Acute and delayed vesicoureteral obstruction after endoscopic treatment of primary vesicoureteral reflux with dextranomer/hyaluronic acid copolymer: why and how to manage.
        J Pediatr Urol. 2013; 9 (Epub 2013 Mar 16. PMID: 23507288): 493-497https://doi.org/10.1016/j.jpurol.2013.02.007
        • Papagiannopoulos D.
        • Rosoklija I.
        • Cheng E.
        • Yerkes E.
        Delayed obstruction with asymptomatic loss of renal function after dextranomer/hyaluronic acid copolymer (deflux) injection for vesicoureteral reflux: a close look at a disturbing outcome.
        Urology. 2017; 101 (Epub 2016 Sep 26. PMID: 27687330): 63-66https://doi.org/10.1016/j.urology.2016.09.013
        • Mesrobian H.G.
        • Kramer S.A.
        • Kelalis P.P.
        Reoperative ureteroneocystostomy: review of 69 patients.
        J Urol. 1985; 133 (PMID: 3973988): 388-390https://doi.org/10.1016/s0022-5347(17)48990-7
        • Broaddus S.B.
        • Zickerman P.M.
        • Morrisseau P.M.
        • Leadbetter Jr., G.W.
        Incidence of later ureteral obstruction after antireflux surgery in infants and children.
        Urology. 1978; 11 (PMID: 628991): 139-141https://doi.org/10.1016/0090-4295(78)90092-4
        • Weiss R.M.
        • Schiff Jr., M.
        • Lytton B.
        Late obstruction after ureteroneocystostomy.
        J Urol. 1971; 106 (PMID: 5564774): 144-148https://doi.org/10.1016/s0022-5347(17)61244-8
        • Filly R.A.
        • Friedland G.W.
        • Fair W.R.
        • Govan D.E.
        Late ureteric obstruction following ureteral reimplantation for reflux: a warning.
        Urology. 1974; 4 (PMID: 4428553): 540-543https://doi.org/10.1016/0090-4295(74)90486-5
        • Mor Y.
        • Leibovitch I.
        • Fridmans A.
        • Farkas A.
        • Jonas P.
        • Ramon J.
        Late post-reimplantation ureteral obstruction during pregnancy: a transient phenomenon?.
        J Urol. 2003; 170 (PMID: 12913713): 845-848https://doi.org/10.1097/01.ju.0000082688.93786.39